Suvretta Capital Management, LLC Arcutis Biotherapeutics, Inc. Transaction History
Suvretta Capital Management, LLC
- $2.91 Billion
- Q2 2025
A detailed history of Suvretta Capital Management, LLC transactions in Arcutis Biotherapeutics, Inc. stock. As of the latest transaction made, Suvretta Capital Management, LLC holds 11,535,582 shares of ARQT stock, worth $195 Million. This represents 5.56% of its overall portfolio holdings.
Number of Shares
11,535,582
Previous 11,422,978
0.99%
Holding current value
$195 Million
Previous $179 Million
9.47%
% of portfolio
5.56%
Previous 7.82%
Shares
10 transactions
Others Institutions Holding ARQT
# of Institutions
240Shares Held
129MCall Options Held
407KPut Options Held
216K-
Jennison Associates LLC11.1MShares$188 Million0.09% of portfolio
-
Rubric Capital Management LP New York, NY10.7MShares$182 Million3.47% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA9.87MShares$167 Million7.3% of portfolio
-
Black Rock Inc. New York, NY8.62MShares$146 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.05MShares$119 Million0.0% of portfolio
About Arcutis Biotherapeutics, Inc.
- Ticker ARQT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,187,500
- Market Cap $1.02B
- Description
- Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing A...